Illinois 2025-2026 Regular Session

Illinois House Bill HB1770

Introduced
1/27/25  
Refer
1/28/25  
Refer
2/25/25  

Caption

INS-HEALTH CARE/RARE CONDITION

Impact

If passed, HB1770 would require insurance policies issued or renewed in Illinois to cover treatments for rare and unique medical conditions without subjecting patients to pre-approval requirements for certain medications. This provision aligns with contemporary healthcare practices, which advocate for greater flexibility for patients with specialized needs. Supporters argue that eliminating pre-approval demands can help expedite treatment for patients whose conditions require more immediate medical attention.

Summary

House Bill 1770 aims to amend the Illinois Insurance Code, specifically adding provisions for the coverage of medically necessary treatments for various genetic and rare conditions. Notably, it emphasizes coverage for specific medical conditions such as Ehlers-Danlos syndrome and acknowledges unique metabolic requirements that may necessitate higher doses of medication. This legislation is intended to ensure that individuals with these conditions can access the necessary pharmaceutical treatments without unnecessary barriers imposed by insurance policies.

Contention

Despite its supportive aims, there may be contention surrounding the bill due to the potential implications for insurance companies and their coverage policies. Critics may argue that mandated coverage for specific conditions could increase operational costs for insurers, potentially leading to higher premiums for all policyholders. The bill also places the onus of proving medical necessity on insurers rather than patients, a shift that advocates for patient rights in accessing required treatments. This aspect might spark further discussion on the balance between insurance company regulations and patient protections.

Companion Bills

No companion bills found.

Previously Filed As

IL HB783

Generally revise health insurance laws relating to certain conditions

IL S1552

Experimental Treatments for Terminal Conditions and Life-threatening Rare Diseases

IL H1381

Experimental Treatments for Terminal Conditions and Life-threatening Rare Diseases

IL HB1461

Health Insurance - Coverage for Specialty Drugs - Rheumatologic Conditions

IL SB1471

INS-HEALTH CARE/AMBULANCE

IL SB230

Authorize pharmacists to test, treat certain health conditions

IL SB2287

INS CD-MENTAL HEALTH CARE

IL SB3900

ALL-PAYER HEALTH CARE PAYMENT

IL SB2943

INS-CLEFT LIP AND PALATE CARE

IL S0294

Collaborative Pharmacy Practice for Chronic Health Conditions

Similar Bills

WI AB925

Revising various provisions of the statutes for the purpose of making corrections and reconciling conflicts (Correction Bill).

AZ HB2944

Inpatient treatment days; computation; exclusion

CA AB1879

Substance use: treatment or residential data reporting.

WI SB904

Revising various provisions of the statutes for the purpose of making corrections and reconciling conflicts (Correction Bill).

CA AB2538

Medi-Cal: hospice providers: forms.

AZ SB1244

court-ordered treatment; continuation

IA HF518

A bill for an act establishing a veterans recovery pilot program and fund for the reimbursement of expenses related to providing hyperbaric oxygen treatment to eligible veterans and making appropriations.(Formerly HF 326.)

IA HF326

A bill for an act establishing a veterans recovery pilot program and fund for the reimbursement of expenses related to providing hyperbaric oxygen treatment to eligible veterans and making appropriations.(See HF 518.)